Document is current
Any future updates will be listed below
-
Authors
Miao, Zhu-Wei
Wang, Zhi
Zheng, Si-Li
Wang, Shu-Na
Miao, Chao-Yu https://orcid.org/0000-0002-8176-3434
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct01287936 at ClinicalTrials.govnct02448641 at ClinicalTrials.govDocuments that mention this clinical trial
Anti-stroke biologics: from recombinant proteins to stem cells and organoids
https://doi.org/10.1136/svn-2023-002883
nct01151124 at ClinicalTrials.govDocuments that mention this clinical trial
Anti-stroke biologics: from recombinant proteins to stem cells and organoids
https://doi.org/10.1136/svn-2023-002883
nct02117635 at ClinicalTrials.govDocuments that mention this clinical trial
Stem cells as a resource for regenerative neurology
https://doi.org/10.1136/jnnp.2010.235184
Anti-stroke biologics: from recombinant proteins to stem cells and organoids
https://doi.org/10.1136/svn-2023-002883
Human neural stem cells in patients with chronic ischaemic stroke (PISCES): a phase 1, first-in-man study
https://doi.org/10.1016/s0140-6736(16)30513-x
nct03541668 at ClinicalTrials.govDocuments that mention this clinical trial
Anti-stroke biologics: from recombinant proteins to stem cells and organoids
https://doi.org/10.1136/svn-2023-002883
Documents that mention this clinical trial
Anti-stroke biologics: from recombinant proteins to stem cells and organoids
https://doi.org/10.1136/svn-2023-002883
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82030110)
National Natural Science Foundation of China (82104166)
National Natural Science Foundation of China (82330117)
- License Information
